Stebėti
Jacek Bil
Jacek Bil
Centre of Postgraduate Medical Education
Patvirtintas el. paštas cmkp.edu.pl
Pavadinimas
Cituota
Cituota
Metai
Statins impair antitumor effects of rituximab by inducing conformational changes of CD20
M Winiarska, J Bil, E Wilczek, GM Wilczynski, M Lekka, PJ Engelberts, ...
PLoS medicine 5 (3), e64, 2008
1582008
Cardiotoxicity of the anticancer therapeutic agent bortezomib
D Nowis, M Mączewski, U Mackiewicz, M Kujawa, A Ratajska, ...
The American journal of pathology 176 (6), 2658-2668, 2010
1482010
Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein response
A Szokalska, M Makowski, D Nowis, GM Wilczynski, M Kujawa, C Wójcik, ...
Cancer research 69 (10), 4235-4243, 2009
1262009
Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice
D Nowis, M Bugajski, M Winiarska, J Bil, A Szokalska, P Salwa, T Issat, ...
BMC cancer 8, 1-12, 2008
832008
Molecular mechanisms of the antitumor effects of anti-CD20 antibodies
M Winiarska, E Glodkowska-Mrowka, J Bil, J Golab
Front Biosci (Landmark Ed) 16 (1), 277-306, 2011
662011
Statins impair glucose uptake in tumor cells
A Malenda, A Skrobanska, T Issat, M Winiarska, J Bil, B Oleszczak, ...
Neoplasia 14 (4), 311-323, 2012
642012
Bortezomib modulates surface CD20 in B-cell malignancies and affects rituximab-mediated complement-dependent cytotoxicity
J Bil, M Winiarska, D Nowis, K Bojarczuk, A Dabrowska-Iwanicka, ...
Blood, The Journal of the American Society of Hematology 115 (18), 3745-3755, 2010
602010
Statins use and cancer: an update
M Zaleska, O Mozenska, J Bil
Future Oncology 14 (15), 1497-1509, 2018
542018
Optical coherence tomography criteria for defining functional severity of intermediate lesions: a comparative study with FFR
T Pawlowski, F Prati, T Kulawik, E Ficarra, J Bil, R Gil
The International Journal of Cardiovascular Imaging 29, 1685-1691, 2013
522013
Statins potentiate cytostatic/cytotoxic activity of sorafenib but not sunitinib against tumor cell lines in vitro
J Bil, L Zapala, D Nowis, M Jakobisiak, J Golab
Cancer letters 288 (1), 57-67, 2010
422010
Regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM (R) stent: the randomised, multicentre, open-label, controlled POLBOS II trial
RJ Gil, J Bil, MJ Grundeken, A Kern, LA Inigo Garcia, D Vassilev, ...
EuroIntervention 12 (11), e1404-e1412, 2016
412016
Dedicated bifurcation paclitaxel‐eluting stent BiOSS Expert® in the treatment of distal left main stem stenosis
J Bil, RJ Gil, D Vassilev, J Rzezak, T Kulawik, T Pawlowski
Journal of Interventional Cardiology 27 (3), 242-251, 2014
402014
Potentiated antitumor effects of the combination treatment with statins and pamidronate in vitro and in vivo
T Issat, D Nowis, M Legat, M Makowski, MP Klejman, J Urbanski, ...
International journal of oncology 30 (6), 1413-1425, 2007
392007
The role of invasive diagnostics and its impact on the treatment of dilated cardiomyopathy: A systematic review
KE Gil, A Pawlak, RJ Gil, M Frontczak-Baniewicz, J Bil
Advances in medical sciences 61 (2), 331-343, 2016
372016
Regular drug-eluting stent vs dedicated coronary bifurcation bioss expert stent: multicenter open-label randomized controlled POLBOS I trial
RJ Gil, J Bil, V Džavík, D Vassilev, A Kern, R Formuszewicz, ...
Canadian Journal of Cardiology 31 (5), 671-678, 2015
342015
Intravascular lithotripsy for the treatment of stent underexpansion: the multicenter IVL-DRAGON registry
W Wańha, M Tomaniak, P Wańczura, J Bil, R Januszek, R Wolny, ...
Journal of Clinical Medicine 11 (7), 1779, 2022
292022
First‐in‐man study of dedicated bifurcation sirolimus‐eluting stent: 12‐month results of BiOSS LIM® registry
RJ Gil, J Bil, D Vassiliev, LA Inigo Garcia
Journal of Interventional Cardiology 28 (1), 51-60, 2015
292015
Platelet distribution width as the prognostic marker in coronary bifurcation treatment
A Kern, RJ Gil, K Bojko, E Sienkiewicz, B Januszko‐Giergielewicz, ...
European Journal of Clinical Investigation 47 (7), 524-530, 2017
282017
Prenyltransferases regulate CD20 protein levels and influence anti-CD20 monoclonal antibody-mediated activation of complement-dependent cytotoxicity
M Winiarska, D Nowis, J Bil, E Glodkowska-Mrowka, A Muchowicz, ...
Journal of Biological Chemistry 287 (38), 31983-31993, 2012
282012
Carcinoid heart disease: how to diagnose and treat in 2020?
B Bober, M Saracyn, M Kołodziej, Ł Kowalski, E Deptuła-Krawczyk, ...
Clinical Medicine Insights: Cardiology 14, 1179546820968101, 2020
262020
Sistema negali atlikti operacijos. Bandykite vėliau dar kartą.
Straipsniai 1–20